Influenza vaccine use in Nunavut: a brief overview of the uptake rates across the regions.
Steenbeek, Audrey A. ; Sobol, Isaac ; MacDonald, Noni E. 等
Dear Editor,
Influenza is a common respiratory illness that affects millions of
Canadians each year. (1) For most healthy adults and children,
infections are not severe, but for vulnerable and/or high-risk
populations such as the elderly, young children, individuals living in
Aboriginal communities and those suffering from chronic health
conditions, influenza can cause serious health consequences and even
death; approximately 4,000-8,000 Canadians die annually from influenza
and/or related complications. (2,3)
Canadian Aboriginal people (e.g., First Nations people, Inuit,
Metis) often face more serious health-related challenges than their
non-Aboriginal counterparts, such as high rates of chronic and
contagious diseases and shorter life expectancy. American statistics
indicate that the influenza illness rate is 3-7 times higher among
Alaskan Natives and Native Americans than in whites. (4) Hence there is
a need to ensure optimal prevention of influenza infection where
possible in Aboriginal communities.
Universal influenza programs are known to limit influenza morbidity
and mortality by: increasing the numbers of people directly protected
from influenza by vaccination and indirectly through herd immunity, and
supporting the development of expertise in vaccine procurement and
delivery systems that may be needed for dealing with an influenza
pandemic. (5)
In the Canadian territories, the Yukon has provided free influenza
vaccines to all residents aged 18 or older since 1999; the Northwest
Territories (NWT) has offered free influenza vaccines to its residents
since 2003, and Nunavut introduced universal vaccination for those aged
6 months and up in the fall of 2005. (3) Unfortunately, influenza
vaccine effectiveness is difficult to quantify in northern Aboriginal
communities (e.g., Nunavut, NWT) because influenza infections are
typically not laboratory confirmed or often not well documented unless
the patient is sent to a hospital. (5)
Has the universal influenza vaccine program led to an increased
uptake in Nunavut?
In 2007-2008, community uptake of influenza vaccine across Nunavut
varied widely across communities - ranging from 12% to 77% of eligible
persons in all three regions (Figure 1). Furthermore, the variation
continued in the 2008-2009 portion of the program (Figure 1) with
overall immunization rates (0-60%) worse than the previous season.
Why the wide variation from community to community?
In non-Aboriginal communities in the south, influenza vaccine
uptake is influenced by a range of factors, including attitudes toward
vaccination; perception of influenza risk and vaccine efficacy;
frequency of health care visits; and most importantly, attitudes of the
health care providers. (4) In the north, where access to care choices is
limited in range, the attitude of the care provider may be especially
influential.
How might influenza vaccine uptake rates be improved in Nunavut?
The first step will be to determine the attitudes and beliefs of
the health care providers running the influenza vaccine program in each
community and contrast these with the uptake rates. If a correlation is
found, then efforts are needed to increase the education and skills of
local health care providers with regard to optimization of influenza
vaccine uptake. Given the high cost of medical evacuation for
complicated influenza cases, this study needs to be done sooner than
later.
Audrey A. Steenbeek, PhD, RN
School of Nursing, Dalhousie University, Halifax, NS
Isaac Sobol, MD, MPH
Nunavut Health & Social Services, Iqaluit, NU
Noni E. MacDonald, MD, MSc
Dept. of Pediatrics, Dalhousie University, IWK Health Centre,
Halifax, NS
REFERENCES
(1.) Health Canada: Diseases and conditions. Available online at:
http://www.hcsc. gc.ca/dc-ma/influenza/index-eng.php (Accessed January
29, 2009).
(2.) Kwong JC, Rosella LC, Johansen H. Trends in influenza
vaccination in Canada, 1996/1997 to 2005. Health Reports
2007;18(4):1-11.
(3.) Public Health Agency of Canada: Influenza. Available online
at: http://www.phac-aspc.gc.ca/influenza/(Accessed January 29, 2009).
(4.) Zimmerman RK, Tabbarah M, Nowalk MP, Raymund MR, Jewell IK,
Hyg MS, et al. Predictors of pneumococcal polysaccharide vaccination
among patients at three inner-city neighborhood health centers. Am J
Geriatric Pharm 2005;3(3):149-59.
(5.) Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur RE, Johansen H,
et al. The effect of universal influenza immunization on mortality and
health care use. PLOS Medicine 2008;5(10):1440-52.
Figure 1. Influenza vaccine uptake for Nunavut per region (2007-09)
Mean % of Total
Population Immunized
2007-08 2008-09
Baffin 12-74% * 0-30% *
Kivalliq 25-77% * 5-60% *
Kitikmeot 22-45% * 10-29% *
* Range of influenza vaccine uptake for the total population per
community within the region
Source: Nunavut Health and Social Services; Public Health Division,
2009.
Note: Table made from bar graph.